Lucid Diagnostics Inc (LUCD)vsStryker Corporation (SYK)
LUCD
Lucid Diagnostics Inc
$1.01
-2.43%
HEALTHCARE · Cap: $187.53M
SYK
Stryker Corporation
$305.66
+2.15%
HEALTHCARE · Cap: $112.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 492109% more annual revenue ($25.27B vs $5.13M). SYK leads profitability with a 13.2% profit margin vs 0.0%. SYK earns a higher WallStSmart Score of 59/100 (C).
LUCD
Avoid29
out of 100
Grade: F
SYK
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LUCD.
Margin of Safety
-35.2%
Fair Value
$223.02
Current Price
$305.66
$82.64 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 51.7% year-over-year
Large-cap with strong market position
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -711.0% — below average capital efficiency
Premium valuation, high expectations priced in
2.6% revenue growth
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LUCD
The strongest argument for LUCD centers on Revenue Growth. Revenue growth of 51.7% demonstrates continued momentum.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap. PEG of 1.43 suggests the stock is reasonably priced for its growth.
Bear Case : LUCD
The primary concerns for LUCD are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 6.70 is elevated, increasing financial risk.
Bear Case : SYK
The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.
Key Dynamics to Monitor
LUCD profiles as a hypergrowth stock while SYK is a value play — different risk/reward profiles.
LUCD carries more volatility with a beta of 1.08 — expect wider price swings.
LUCD is growing revenue faster at 51.7% — sustainability is the question.
SYK generates stronger free cash flow (415M), providing more financial flexibility.
Bottom Line
SYK scores higher overall (59/100 vs 29/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lucid Diagnostics Inc
HEALTHCARE · MEDICAL DEVICES · USA
Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.
Visit Website →Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?